TO STUDY IODINE VERSUS TALC PLEURODESIS IN RECURRENT SUSPICIOUS MALIGNANT PLEURAL EFFUSION AND RECURRENT PNEUMOTHORAX: A COHORT STUDY.
DOI:
https://doi.org/10.51168/sjhrafrica.v5i6.1225Keywords:
Malignant pleural effusion, Pleurodesis, Talc, Povidone-iodine, ThoracoscopyAbstract
Background
Malignant pleural effusion (MPE) significantly diminishes the quality of life in individuals with advanced lung cancer and other malignancies. Effective management is crucial for symptom relief and improved outcomes. This study compares the safety, efficacy, and success rates of talc versus povidone-iodine pleurodesis in patients with recurrent MPE and spontaneous pneumothorax.
Methods
The study involved 66 MPE patients who underwent medical thoracoscopy followed by either talc (Group A) or povidone-iodine (Group B) pleurodesis. Data on demographics, clinical presentation, radiological findings, pleural fluid analysis, thoracoscopic findings, complications, and pleurodesis outcomes were collected. Statistical analysis compared the efficacy and safety of both methods.
Results
The study comprised 66 participants, with an average age of 57.86 ± 9.92 years. Pleurodesis was successful in 90.90% of the talc group (n=30) and 100% of the povidone-iodine group (n=33). Complications associated with talc included ARDS (4.5%, n=1) and empyema (4.5%, n=1), whereas povidone-iodine was associated with higher incidences of pain (63.63%, n=14) but no cases of ARDS or empyema. The mean duration of intercostal tube drainage was 4.8 ± 2.1 days for talc and 4.2 ± 1.8 days for povidone-iodine. The mean hospital stay was 8.4 ± 1.8 days for talc and 9.2 ± 2.2 days for povidone-iodine. Povidone-iodine pleurodesis had a slightly higher success rate and fewer severe complications compared to talc pleurodesis.
Conclusion
Both talc and povidone-iodine pleurodesis are effective for managing MPE, with povidone-iodine showing a higher success rate and fewer severe complications. These findings suggest that povidone-iodine may be a safer alternative to talc for pleurodesis in MPE patients.
Recommendations
Further research is recommended to optimize pleurodesis techniques and agents, considering patient-specific factors to improve outcomes and minimize complications. Clinicians should weigh the benefits and risks of each pleurodesis agent to make informed treatment decisions.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Swadesh Kumar Mohanty, R S Negi, Sunil Sharma, Smita Rani Samal
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.